Tilak Mandadi - Apr 1, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Technology Officer
Signature
/s/ Tilak Mandadi
Stock symbol
CVS
Transactions as of
Apr 1, 2024
Transactions value $
$5,403,715
Form type
4
Date filed
4/3/2024, 04:49 PM
Previous filing
Sep 1, 2023
Next filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (RSU) Award $0 +16.3K +24.55% $0.00 82.9K Apr 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $5.4M +67.9K $79.56 67.9K Apr 1, 2024 Common Stock 67.9K $79.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.
F2 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.